Business
If only Ellume was an ASX share! Why it’s making big news today
For an unlisted company, Ellume certainly knows how to keep ASX investors talking. The Brisbane-based health company also made news last year. This was due to its announcement that the United States Food and Drug Administration (FDA) had endorsed one of its products.
As we discussed at the time, Ellume specialises in rapid diagnostic technology. The company had developed a rapid test for the COVID-19 infection. The test only costs around US$30. It can reportedly detect traces of coronavirus in as little as 15 minutes with a 94% sensitivity in detecting infection.
Following that endorsement from the FDA, Ellume ramped up plans to send more than 100,000 of its tests to the US. At the time, Ellume planned on delivering more than 5…
-
Noosa News12 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General22 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Business21 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News23 hours agoUrgent recall notice issued for deli meats over contamination risk